Mobile Menu




Media Inquiries

Drew Hoffman



August 10, 2022

Zeno Celebrates Key Milestones in Customer Acquisition, Product Growth

Zeno Technologies, a pioneer in helping businesses master the financial performance of their energy assets, has achieved significant traction following the company’s public launch in October 2021. In just nine months since emerging from stealth, Zeno won key client engagements and expanded its product offering to help energy businesses exert better capital discipline to deliver predictable returns to their investors.

Read More

July 19, 2022

Deka Biosciences Breaks Ground on New Facility

Deka Biosciences announced today that it is breaking ground on a 14,000 square foot office and lab which will house a state of the art Research and Development, Process Development, and Manufacturing facility to further develop their novel cytokine therapies. This will be the first facility to house a dual targeted cytokine development lab in the DC/Maryland/Virginia region and the only company in the US developing a therapeutic of its kind. The new headquarters will be located at 20380 Seneca Meadows Parkway in Germantown, Maryland and Deka anticipates the move to be completed in the first quarter of 2023.

Read More

May 3, 2022

'We have to think differently.' OKC vies for $55M grant to grow biosciences industry

A group of Oklahoma City’s leading civic, bio-science and university players pitched a vision Monday on how they hope to work together to use a $55 million Economic Development Administration Grant to further build up the region’s growing innovation cluster.

Read More

February 24, 2022

Multi-Disciplinary Investment Firm Echo Investment Capital Announces Partial Mineral/Royalty Sale

Echo Investment Capital’s affiliate, Echo Minerals, announces its agreement to sell mineral and royalty interests to Austin, Texas-based Brigham Minerals, Inc. (NYSE: MNRL) for a total value of $32.5 million. Echo is a multi-strategy firm spanning life sciences, media and entertainment, real estate, and energy.

Read More

January 4, 2022

Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC™

Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round. The round was co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation.

Read More

Let’s build something great together.